Sentinel node biopsy with technetium-99m colloidal rhenium sulphide in patients with breast cancer

British Journal of Surgery

Volumn 88, Issue 5, 2001, Pages 704-707

  Watanabe, T ^a   Kimijima, I ^a   Ohtake, T ^a   Tsuchiya, A ^a   Shishido, F ^a   Takenoshita, S ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NANOCIS; RHENIUM SULFIDE COLLOID TC 99M;

ARTICLE; AXILLARY LYMPH NODE; BREAST; BREAST CARCINOMA; CONTROLLED STUDY; HUMAN; INJECTION; ISOTOPE LABELING; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; PARTICLE SIZE; PERIOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RADIODIAGNOSIS; SENTINEL LYMPH NODE BIOPSY; SURGICAL APPROACH;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; RHENIUM; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM TC 99M SULFUR COLLOID;

EID: 0035662930     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2168.2001.01767.x     Document Type: Article

References (25)

1. Interstitial lymphoscintigraphy for lymphatic mapping in surgical practice and research
2. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer
3. Management of early-stage melanoma by intraoperative lymphatic mapping and selective lymphadenectomy. An alternative to routine elective lymphadenectomy or 'watch and wait'
4. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe
5. Lymphatic mapping and sentinel lymphadenectomy for breast cancer
6. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes
7. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer
8. Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer
9. Can sentinel node biopsy avoid axillary dissection in clinically node-negative breast cancer patients?
10. Sentinel lymph node biopsy in breast cancer: Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection
11. Sentinel node biopsy in breast cancer: Initial experience at Memorial Sloan-Kettering Cancer Center
12. Sentinel node biopsy in breast cancer
13. Routine preoperative lymphoscintigraphy is not necessary prior to sentinel node biopsy for breast cancer
14. Particle sizing and biokinetics of interstitial lymphoscintigraphic agents
15. Sentinel lymph node mapping in breast cancer
16. Sentinel lymph node biopsy and axillary dissection in breast cancer: Results in a large series
17. Radiolabeled colloids and macromolecules in the lymphatic system
18. Lymphoscintigraphy, the sentinel node concept, and the intraoperative gamma probe in melanoma, breast cancer, and other potential cancers
19. Radiopharmaceuticals in sentinel lymph-node detection - An overview
20. Radiopharmaceuticals for lymphoscintigraphy: Including dosimetry and radiation considerations
21. The sentinel node in breast cancer - A multicenter validation study
22. Sentinel node staging of early breast cancer using lymphoscintigraphy and the intraoperative gamma-detecting probe
23. Gamma probe-guided sentinel node biopsy - Optimal timing for injection
24. Practical guidelines for optimal gamma probe detection of sentinel lymph node in breast cancer: Results of a multi-institutional study. For the University of Louisville Breast Cancer Study Group
25. Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer